Condition: Acute Pancreatitis · Acute Pancreatitis With Infected Necrosis · Sponsor: University Medical Center Goettingen
The goal of this observational study is to evaluate the orointestinal microbiome and microbial derived metabolome in patients suffering from acute pancreatitis as a biomarker for severity. The main questions it aims to answer are: * Can the orointestinal microbiome robustly predict the course of acute pancreatitis? * How does the microbiome impact the severity of an acute pancreatitis? Buccal/ rectal swabs, plasma and stool is collected from patients with acute pancreatitis within 48h after hospital admission.
This description comes directly from the study's public registry record.
Christoph Ammer-Herrmenau, Dr · +491704075339 · christoph.herrmenau@med.uni-goettingen.de
Jacob Hamm, Dr · +495513963231 · jacob.hamm@med.uni-goettingen.de
Always discuss trial participation with your own doctor first.
| University Medical Center Goettingen | Göttingen, Lower Saxony, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06508502